G
G

GSK


News

FTSE 100 lags European peers on strong pound

(For a Reuters live blog on U.S., UK and European stock markets, click LIVE/ or type LIVE/ in a news window) * Imperial Brands up first-half sales rise * UK unemployment hits 48-year low * ContourGlobal soars on KKR buyout offer * FTSE 100 up 0.7%, FTSE 250 adds 0.7% (Updates to close) By Sruthi Shankar May 17 (Reuters) - UK stocks advanced on Tues
A
A
G
I
N
U

Financials and healthcare shares lift FTSE 100

(For a Reuters live blog on U.S., UK and European stock markets, click LIVE/ or type LIVE/ in a news window) * Renishaw down after engineering firm cuts profit forecast * UK shoppers cut spending as inflation squeeze tightens * FTSE 100 and FTSE 250 both up 0.4% (Updates to close) By Bansari Mayur Kamdar May 10 (Reuters) - Britain's FTSE 100 rose o
A
A
B
G
R
N
U

Healthcare, consumer staples weigh on London's FTSE 100

(For a Reuters live blog on U.S., UK and European stock markets, click LIVE/ or type LIVE/ in a news window) * Liberum cuts Rio Tinto's rating to "sell" from "hold" * HSBC up as it launches $1 billion planned share buyback * Boohoo tumbles on profit drop, warning of tough year ahead * FTSE 100 down 0.9%, FTSE 250 off 1.5% (Updates to close) By Bans
A
D
G
U

British Business - May 4

May 4 (Reuters) - The following are the top stories on the business pages of British newspapers. Reuters has not verified these stories and does not vouch for their accuracy. The Times - Former employees of the Bank of England, the institution responsible for controlling inflation, may soon be the only pensioners in the country more than fully insu
B
G

UK Stocks-Factors to watch on April 27

April 27 (Reuters) - Britain's FTSE 100 index .FTSE is seen opening higher on Wednesday, with futures FFIc1 up 0.26%. * GSK: British drugmaker GSK GSK.L beat analyst expectations for its first-quarter profit and sales, ahead of the planned listing of its large consumer healthcare division in July, and stood by its forecasts for 2022. * LSE: The Lon
D
G
H
L
P
W
W
A
T
U

UK Stocks-Factors to watch on April 27

April 27 (Reuters) - Britain's FTSE 100 index .FTSE is seen opening flat on Wednesday, with futures FFIc1 down 0.09%. * BANK OF IRELAND: Bank of Ireland BIRG.I said that Chief Executive Francesca McDonagh would step down after five years in charge that saw the bank grow through acquisition, sharply cut staff numbers and almost fully return to priva
D
G
H
L
P
W
W
A
U

Financial Times - April 21

April 21 (Reuters) - The following are the top stories in the Financial Times. Reuters has not verified these stories and does not vouch for their accuracy. Headlines - Financial regulator moves to boost number of women in UK boardrooms Link - GSK workers vote to strike over below inflation pay rise Link - Oaktree-backed 17Capital raises almost $3
G

British Business - April 14

April 14 (Reuters) - The following are the top stories on the business pages of British newspapers. Reuters has not verified these stories and does not vouch for their accuracy. The Times - Messages between Essex-based oil traders said to have made more than $700 million from the 2020 oil price crash provide a "highly plausible inference" that they
G
T

UK Stocks-Factors to watch on April 7

April 7 (Reuters) - Britain's FTSE 100 index .FTSE is seen opening flat on Thursday, with futures FFIc1 marginally up 0.18%. * SHELL: Shell SHEL.L will write down up to $5 billion in the first quarter as a result of its decision to exit Russia, higher than previously disclosed, while its oil and gas trading activities are set to get a boost from so
G
U

UK Stocks-Factors to watch on April 7

April 7 (Reuters) - Britain's FTSE 100 index .FTSE is seen opening flat on Thursday, with futures FFIc1 down 0.03%. * SHELL-MITSUBISHI: Japan's Mitsubishi Corp 8058.T and Shell Plc SHEL.L aim to produce 400,000 tonnes of "green hydrogen" in 2030 through the companies' European offshore wind power project, the Yomiuri newspaper reported. * GSK: Brit
G
U

UK Stocks-Factors to watch on April 6

April 6 (Reuters) - Britain's FTSE 100 index .FTSE is seen opening flat on Wednesday, with futures FFIc1 up 0.1%. * LOOKERS: Lookers Plc LOOK.L reinstated its dividend after reporting a higher profit as demand for cars picked up last year after lockdowns were lifted, although the auto retailer warned of higher costs due to inflationary pressures in
G
I
U

UK Stocks-Factors to watch on April 6

April 6 (Reuters) - Britain's FTSE 100 index .FTSE is seen opening flat on Wednesday, with futures FFIc1 up 0.1%. * GSK-VIR: The U.S. health regulator said GlaxoSmithKline GSK.L and Vir Biotechnology's VIR.O antibody therapy was no longer authorized as a COVID-19 treatment, with data suggesting it was unlikely to be effective against the dominant O
G
I
U

Sanofi targets Dupixent peak sales of over 13 bln euros

PARIS, March 29 (Reuters) - French healthcare group Sanofi SASY.PA , which lagged rivals in the race for COVID-19 vaccines, raised on Tuesday its peak sales target for eczema-treatment product Dupixent to more than 13 billion euros ($14.3 billion). "This new ambition does not include potential for additional sales ambition upgrade from chronic obst
G
R
S

Healthcare group Sanofi targets Dupixent peak sales of over 13 bln euros

PARIS, March 29 (Reuters) - French healthcare group Sanofi SASY.PA , which lagged rivals in the race for COVID-19 vaccines, raised on Tuesday its peak sales target for eczema-treatment product Dupixent to more than 13 billion euros ($14.3 billion). "This new ambition does not include potential for additional sales ambition upgrade from chronic obst
G
R
S

Financial Times - March 1

March 1 (Reuters) - The following are the top stories in the Financial Times. Reuters has not verified these stories and does not vouch for their accuracy. Headlines - GSK expects to spin off Haleon consumer business in July. Link - Flutter ties staff bonuses to curbing problem gambling Link - Boris Johnson warns of UK energy price shock Link - Air
A
G
F

UK Stocks-Factors to watch on Feb 28

Feb 28 (Reuters) - Britain's FTSE 100 index .FTSE is seen opening lower on Monday, with futures FFIc1 down 1.22%. * AB FOODS: Associated British Foods ABF.L forecast first-half sales and adjusted operating profit "strongly ahead" of the previous year and ahead of pre-COVID 19 levels, reflecting an improved performance from its Primark fashion busin
B
E
G
M
A
R
U

UK Stocks-Factors to watch on Feb 28

Feb 28 (Reuters) - Britain's FTSE 100 index .FTSE is seen opening 99 points lower at 7,353.5 on Monday, according to financial bookmakers. * RIO TINTO: Rio Tinto RIO.L RIO.AX has agreed to pay a small penalty for overstating its Mozambique coal reserves in 2012 in return for the Australian corporate watchdog dropping charges against its top two exe
B
E
G
M
A
R
U

UK Stocks-Factors to watch on Feb 24

Feb 24 (Reuters) - Britain's FTSE 100 index .FTSE is seen opening lower on Thursday, with futures FFIc1 down 2.04%. * SANOFI-GSK: French drugmaker Sanofi SASY.PA and its British partner GlaxoSmithKline GSK.L are seeking regulatory approval for their COVID-19 vaccine to be used as a booster, as well as a standalone two-dose shot, after several setba
A
B
B
C
D
D
G
H
I
L
S
S
W
R
U

British Business - Feb 24

Feb 24 (Reuters) - The following are the top stories on the business pages of British newspapers. Reuters has not verified these stories and does not vouch for their accuracy. The Times - Britain's official climate advisers have left the door open for the government to approve more North Sea oil and gas drilling, saying that the impact on the plane
B
G
S

Financial Times - Feb 24

Feb 24 (Reuters) - The following are the top stories in the Financial Times. Reuters has not verified these stories and does not vouch for their accuracy. Headlines Sanofi and GSK to seek approval for delayed COVID-19 vaccine. Link UK should bring forward tax rises to fight inflation, IMF says. Link UK warned future exploration of North Sea risks u
G
S



Conditions

Popular Assets

Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.

All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.

Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.

We are using cookies to give you the best experience on our website. Read more or change your cookie settings.

Risk Warning: Your capital is at risk. Leveraged products may not be suitable for everyone. Please consider our Risk Disclosure.